NCT03737656View on ClinicalTrials.gov

Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal Women

PHASE1CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

May 3, 2019

Study Completion Date

May 9, 2019

Conditions

Pharmacokinetics

Interventions

DRUG

Progesterone vaginal ring

Vaginal ring with 2.0 g progesterone (sustained-release over 90-days)

Trial Locations (1)

C.P. 14610

Investigacíon Farmacológica y Biofarmacéutica (IFaB), S.A.P.I. de C.V., Mexico City

Sponsors

Lead Sponsor

Grünenthal GmbH

All Listed Sponsors

collaborator

Grünenthal, S.A.

INDUSTRY

lead

Grünenthal GmbH

INDUSTRY

NCT03737656 - Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal Women | Biotech Hunter | Biotech Hunter